#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4822225	Binding	Inhibition of human His-tagged PERK expressed in Escherichia coli assessed as eIF2alpha phosphorylation by TR-FRET assay	Homo sapiens	32	ALA4819104	assay format	Scientific Literature
2.	ALA4822226	Binding	Inhibition of eIF2alpha (unknown origin) assessed as eIF2alpha phosphorylation by TR-FRET assay	Homo sapiens	30	ALA4819104	single protein format	Scientific Literature
3.	ALA4822227	Physicochemical	Aqueous solubility of the compound		6	ALA4819104	small-molecule physicochemical format	Scientific Literature
4.	ALA4822228	ADME	Apparent permeability of the compound across apical to basolateral side in human Caco-2 cells	Homo sapiens	6	ALA4819104	cell-based format	Scientific Literature
5.	ALA4822229	ADME	Efflux ratio of apparent permeability in human Caco-2 cells	Homo sapiens	6	ALA4819104	cell-based format	Scientific Literature
6.	ALA4822230	ADME	Plasma protein binding in human	Homo sapiens	6	ALA4819104	cell-free format	Scientific Literature
7.	ALA4822231	ADME	Plasma protein binding in rat	Rattus norvegicus	6	ALA4819104	cell-free format	Scientific Literature
8.	ALA4822232	ADME	Plasma protein binding in mouse	Mus musculus	6	ALA4819104	cell-free format	Scientific Literature
9.	ALA4822233	ADME	Plasma protein binding in dog	Canis lupus familiaris	6	ALA4819104	cell-free format	Scientific Literature
10.	ALA4822234	ADME	Half life in human hepatocytes	Homo sapiens	6	ALA4819104	cell-based format	Scientific Literature
11.	ALA4822235	ADME	Half life in rat hepatocytes	Rattus norvegicus	6	ALA4819104	cell-based format	Scientific Literature
12.	ALA4822236	ADME	Half life in mouse hepatocytes	Mus musculus	6	ALA4819104	cell-based format	Scientific Literature
13.	ALA4822237	ADME	Half life in dog hepatocytes	Canis lupus familiaris	6	ALA4819104	cell-based format	Scientific Literature
14.	ALA4822238	Binding	Inhibition of human non-phosphorylated ABL1 F317L mutant (S229 to K512 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4819104	assay format	Scientific Literature
15.	ALA4822239	Binding	Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4819104	assay format	Scientific Literature
16.	ALA4822240	Binding	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4819104	assay format	Scientific Literature
17.	ALA4822241	Binding	Inhibition of wild-type human partial length CSF1R (I564 to S939 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4819104	assay format	Scientific Literature
18.	ALA4822242	Binding	Inhibition of wild-type human partial length DDR1 (R565 to V876 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4819104	assay format	Scientific Literature
19.	ALA4822243	Binding	Inhibition of wild-type human partial length KIT (I571 to D952 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4819104	assay format	Scientific Literature
20.	ALA4822244	Binding	Inhibition of wild-type human full length p38-gamma (M1 to L367 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4819104	assay format	Scientific Literature